Advertisement
Screener

GRAIL, Inc. (GRAL) Capital Expenditures Incurred but Not yet Paid

3.3 / 5 stars · 13/20 Roast Me

GRAIL, Inc. Capital Expenditures Incurred but Not yet Paid

GRAIL, Inc. (GRAL) reported Capital Expenditures Incurred but Not yet Paid of $89.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06

  • GRAIL, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$164.00K.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $253.00K, a 5.60% decline year-over-year.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$28.00K.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$57.00K.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $42.00K.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $1.33M, a 31.65% decline from fiscal 2023.
  • GRAIL, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $1.94M.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 month
2026-06-30-$164.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$89.00K
10-Q · filed 2026-08-06
$61.00K
derived: sum of 3 quarters · filed 2026-08-06
$4.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$253.00K
10-Q · filed 2026-05-07
$225.00K
derived: sum of 2 quarters · filed 2026-05-07
$168.00K
derived: sum of 3 quarters · filed 2026-05-07
$27.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$85.00K
derived: sum of 2 quarters · filed 2026-03-12
-$226.00K
derived: sum of 3 quarters · filed 2026-08-06
$42.00K
10-K · filed 2026-03-12
2025-09-30-$57.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$198.00K
derived: sum of 2 quarters · filed 2026-08-06
$70.00K
10-Q · filed 2025-11-13
-$161.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$141.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$127.00K
10-Q · filed 2026-08-06
-$104.00K
derived: sum of 3 quarters · filed 2026-08-06
-$501.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$268.00K
10-Q · filed 2026-05-07
$37.00K
derived: sum of 2 quarters · filed 2026-05-07
-$360.00K
derived: sum of 3 quarters · filed 2026-05-07
-$325.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$231.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$628.00K
derived: sum of 2 quarters · filed 2026-03-12
-$593.00K
derived: sum of 3 quarters · filed 2026-03-12
$0.00
10-K · filed 2026-03-12
2024-09-30-$397.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$362.00K
derived: sum of 2 quarters · filed 2025-11-13
$231.00K
10-Q · filed 2025-11-13
$470.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30$35.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$628.00K
10-Q · filed 2025-08-13
$867.00K
derived: sum of 3 quarters · filed 2026-03-12
$819.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31$593.00K
10-Q · filed 2025-05-14
$832.00K
derived: sum of 2 quarters · filed 2026-03-12
$784.00K
derived: sum of 3 quarters · filed 2026-03-12
2023-12-31$239.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$191.00K
derived: sum of 2 quarters · filed 2026-03-12
$1.33M
10-K · filed 2025-03-05
2023-10-01-$48.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$1.09M
10-Q · filed 2024-11-13
2023-06-30$1.14M
10-Q · filed 2024-08-13
2023-01-01$1.94M
10-K · filed 2025-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
RadNet, Inc. (RDNT)United States$5.611B-229.65
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70